ペースメーカーの世界市場2018–2025:製品別(インプラント、外付け)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)

【英語タイトル】Pacemaker Market Share Analysis Report By Product (Implantable, External), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), And Segment Forecasts, 2018 - 2025

Grand View Researchが出版した調査資料(GVIEW803021)・商品コード:GVIEW803021
・発行会社(調査会社):Grand View Research
・発行日:2018年2月8日
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥826,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,034,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ペースメーカーの世界市場について調査・分析し、ペースメーカーの世界市場動向、ペースメーカーの世界市場規模、市場予測、セグメント別ペースメーカー市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global pacemaker market size is expected to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 7.2% CAGR during the forecast period. Heightening prevalence of cardiac conditions, coupled with rising availability of medical coverage, is a key driving factor governing the growth of the pacemaker market globally. In addition, technological enhancements in these devices are supporting market expansion.
Increasing prevalence of cardiovascular diseases (CVDs) is a high-impact growth-rendering factor. The World Health Organization reported an estimated 17.5 million deaths stemming from CVDs in 2012. Currently, high occurrence of CVDs is a key concern and in order to address this, government organizations and market participants are channelizing funds and efforts to offer the best possible cure. This is anticipated to foster R&D initiatives and increase the influx of advanced products in this marketspace.

Additionally, increasing awareness about cardiovascular disorders and their long-term impact is raising the preference of patients for advanced treatment options. This is expected to bolster the usage rate of these products. On the other hand, these devices are cost prohibitive, with the price of a pacemaker ranging from USD 10,000 to USD 30,000. This is likely to restrain the growth of the market.

Further key findings from the study suggest:

• Implantable pacemakers held a lucrative share in 2016 and are likely to grow at a profitable rate over the forecast period

• North America, owing to its planned healthcare network, greater per capita income, and increasing awareness levels about adverse effects of a prolonged cardiac condition, has retained a large share in the global pacemaker market

• Economic development in countries such as India and China, unmet needs of a massive population, and supportive initiatives undertaken by governments to improve healthcare access are projected to present avenues for investment in the Asia Pacific market

• Some of the key players operating in this space are Medtronic; BIOTRONIK, Inc.; Boston Scientific Corporation; St. Jude Medical; ZOLL Medical Corporation; MEDICO S.p.A.; Vitatron; Pacetronix; and Cordis, Inc.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Pacemaker Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis – Porter’s
Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis
4.1. Pacemaker Movement Analysis & Market Share, 2016 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following products:
4.2.1. Implantable
4.2.1.1. Single Chamber
4.2.1.2. Dual Chamber
4.2.1.3. Biventricular
4.2.2. External
Chapter 5. Pacemaker Market: Regional Estimates & Trend Analysis
5.1. Pacemaker Movement Analysis & Market Share, 2016 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.3. Europe
5.3.1. U.K.
5.3.1.1. U.K. revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia revenue estimates and forecasts by, product, 2014 – 2025 (USD Million)
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Medtronic
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. BIOTRONIK
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Boston Scientific Corporation
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. St. Jude Medical
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. ZOLL Medical Corporation
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Vitatron
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. MEDICO S.p.A.
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Pacetronix
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Cordis, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives

List of Tables

1. North America pacemaker market, by product, 2014 - 2025 (USD Million)
2. U.S. pacemaker market, by product, 2014 - 2025 (USD Million)
3. Canada pacemaker market, by product, 2014 - 2025 (USD Million)
4. Europe pacemaker market, by product, 2014 - 2025 (USD Million)
5. U.K. pacemaker market, by product, 2014 - 2025 (USD Million)
6. Germany pacemaker market, by product, 2014 - 2025 (USD Million)
7. Asia Pacific pacemaker market, by product, 2014 - 2025 (USD Million)
8. Japan pacemaker market, by product, 2014 - 2025 (USD Million)
9. China pacemaker market, by product, 2014 - 2025 (USD Million)
10. Latin America pacemaker market, by product, 2014 - 2025 (USD Million)
11. Brazil pacemaker market, by product, 2014 - 2025 (USD Million)
12. Mexico pacemaker market, by product, 2014 - 2025 (USD Million)
13. MEA pacemaker market, by product, 2014 - 2025 (USD Million)
14. South Africa pacemaker market, by product, 2014 - 2025 (USD Million)
15. Saudi Arabia pacemaker market, by product, 2014 - 2025 (USD Million)

List of Figures

1. Market summary
2. Market trends & outlook
3. Market segmentation & scope
4. Market driver relevance analysis (Current & Future Impact)
5. Market restraint relevance analysis (Current & Future Impact)
6. Penetration & growth prospect mapping
7. Healthcare predictive analytics PEST by SWOT analysis
8. Porter’s five forces analysis
9. Pacemaker market application outlook key takeaways
10. Pacemaker: Product movement analysis
11. Implantable pacemaker market 2014 - 2025 (USD Million)
12. Single chambered pacemaker market 2014 - 2025 (USD Million)
13. Dual chamber pacemaker market 2014 - 2025 (USD Million)
14. Biventricular pacemaker market 2014 - 2025 (USD Million)
15. Regional market place: Key takeaways
16. Regional outlook, 2016 & 2025
17. North America pacemaker market, 2014 - 2025 (USD Million)
18. U.S. pacemaker market, 2014 - 2025 (USD Million)
19. Canada pacemaker market, 2014 - 2025 (USD Million)
20. Europe pacemaker market, 2014 - 2025 (USD Million)
21. U.K. pacemaker market, 2014 - 2025 (USD Million)
22. Germany pacemaker market, 2014 - 2025 (USD Million)
23. Asia Pacific pacemaker market, 2014 - 2025 (USD Million)
24. Japan pacemaker market, 2014 - 2025 (USD Million)
25. China pacemaker market, 2014-2025 (USD Million)
26. Latin America pacemaker market, 2014 - 2025 (USD Million)
27. Brazil pacemaker market, 2014 - 2025 (USD Million)
28. Mexico pacemaker market, 2014 - 2025 (USD Million)
29. MEA pacemaker market, 2014 - 2025 (USD Million)
30. South Africa pacemaker market, 2014 - 2025 (USD Million)
31. Saudi Arabia pacemaker market, 2014 - 2025 (USD Million)

★調査レポート[ペースメーカーの世界市場2018–2025:製品別(インプラント、外付け)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)] (コード:GVIEW803021)販売に関する免責事項を必ずご確認ください。
★調査レポート[ペースメーカーの世界市場2018–2025:製品別(インプラント、外付け)、地域別(北米、ヨーロッパ、太平洋アジア、ラテンアメリカ、中東・アフリカ)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆